Despite positive data, mainstream medicine is ignoring an affordable COVID medicine. Action Alert! The Frontline COVID-19 Critical Care Alliance (FLCCC) published a paper reviewing the evidence for ivermectin, an off-patent drug for river blindness, arguing that it has antiviral and anti-inflammatory properties that make it effective in the prevention and treatment of COVID. The evidence
Despite positive data, mainstream medicine is ignoring an affordable COVID medicine. Action Alert! The Frontline COVID-19 Critical Care Alliance (FLCCC) published a paper reviewing the evidence for ivermectin, an off-patent drug for river blindness, arguing that it has antiviral and anti-inflammatory properties that make it effective in the prevention and treatment of COVID.
